Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discusses how early data from ABBV-706 shows up to 50% ...

Small cell lung cancer is a type of neuroendocrine tumor (NET). Learn more about the different NETs, including how risk factors, diagnosis, and treatment differ.

Small-cell lung cancer (SCLC) is the most common type of lung neuroendocrine tumor (NET). We review what that means and discuss other types of NETs.

Small cell lung cancer (SCLC) is one of the hardest types of cancer to treat and has often already spread by the time people are diagnosed. It mainly arises from neuroendocrine (NE) cells, which ...

“At just 40% of the administered dose reported for Ac-DOTATATE, Ac-EBTATE produces enhanced anti-tumor efficacy in small cell lung cancer (SCLC) and Pan-neuroendocrine tumor (NET) models as ...

AbbVie is exploring this approach with Temab-A in a trial spanning at least seven tumor types, including lung and colorectal cancers being the most advanced. Another investigational therapy, ABBV-706, ...

SHANGHAI & CAMBRIDGE, Mass., June 02, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Researchers have identified 5 key genes that may serve as new treatment targets for small cell lung cancer (SCLC), according to research published in Frontiers in Immunology. 1. The study found ...

Neuroendocrine tumor surgery—Some people benefit from surgically removing all or part of a neuroendocrine tumor. Surgery may also help control symptoms and delay the need to take medication. Liver ...

Significant and dose-dependent tumor growth inhibition and cell state differentiation was observed in vivo following oral dosing of AUTX-703 in a SCLC patient derived xenograft model.